Cells
(May 2022)
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?
Marco Audisio,
Consuelo Buttigliero,
Fabio Turco,
Marco Donatello Delcuratolo,
Chiara Pisano,
Elena Parlagreco,
Rosario Francesco Di Stefano,
Lavinia Di Prima,
Veronica Crespi,
Giovanni Farinea,
Massimiliano Cani,
Marcello Tucci
Affiliations
Marco Audisio
Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10124 Turin, Italy
Consuelo Buttigliero
Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10124 Turin, Italy
Fabio Turco
Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10124 Turin, Italy
Marco Donatello Delcuratolo
Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10124 Turin, Italy
Chiara Pisano
Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10124 Turin, Italy
Elena Parlagreco
Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10124 Turin, Italy
Rosario Francesco Di Stefano
Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10124 Turin, Italy
Lavinia Di Prima
Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10124 Turin, Italy
Veronica Crespi
Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10124 Turin, Italy
Giovanni Farinea
Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10124 Turin, Italy
Massimiliano Cani
Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10124 Turin, Italy
Marcello Tucci
Department of Medical Oncology, Cardinal Massaia Hospital, 14100 Asti, Italy
DOI
https://doi.org/10.3390/cells11101614
Journal volume & issue
Vol. 11,
no. 10
p.
1614
Abstract
Read online
Urothelial cancer is a lethal malignancy characterized by a wide diffusion in Western countries due to a larger exposure to known risk factors, such as aromatic amines, tobacco smoke and benzene [...]
Keywords
WeChat QR code
Close